18 research outputs found
Aerosol Route to Antibacterial Nanosilver Coating of Cotton Fabrics
The paper describes a gas phase process for the preparation of cotton fabrics coated with silver nanoparticles as antimicrobial agents. Silver nanoparticles are synthesized by means of atmospheric pressure electrical discharges (spark discharge and glow discharge) in pure inert gases, and the aerosols are passed through cotton fabric samples, where nanoparticles deposit. The particle size distribution of the aerosols is measured online during synthesis. Also, the cristallinity, size and morphology of the silver particles are analyzed. The mean size of the primary particles of silver varies from 4 nm to 18 nm, depending upon the type of discharge, the nature and flow rate of the gas. The bactericidal activity of the cotton samples doped with silver nanoparticles is assessed following the ISO 20743 method. All cotton samples show significant bactericidal property, although it degrades with increasing primary particle size and particle agglomeration. This purely physical aerosol route is a promising sustainable method for nanocoating of textiles
Immediate vs. deferred switching from a boosted protease inhibitor (PI/r) based regimen to a Dolutegravir (DTG) based regimen in virologically suppressed patients with high cardiovascular risk or Age ≥50 years: final 96 weeks results of NEAT 022 study
Background
Both immediate and deferred switching from a ritonavir-boosted protease inhibitor (PI/r)–based regimen to a dolutegravir (DTG)–based regimen may improve lipid profile.
Methods
European Network for AIDS Treatment 022 Study (NEAT022) is a European, open-label, randomized trial. Human immunodeficiency virus (HIV)–infected adults aged ≥50 years or with a Framingham score ≥10% were eligible if HIV RNA was <50 copies/mL. Patients were randomized to switch from PI/r to DTG immediately (DTG-I) or to deferred switch at week 48 (DTG-D). Week 96 endpoints were proportion of patients with HIV RNA <50 copies/mL, percentage change of lipid fractions, and adverse events (AEs).
Results
Four hundred fifteen patients were randomized: 205 to DTG-I and 210 DTG-D. The primary objective of noninferiority at week 48 was met. At week 96, treatment success rate was 92.2% in the DTG-I arm and 87% in the DTG-D arm (difference, 5.2% [95% confidence interval, –.6% to 11%]). There were 5 virological failures in the DTG-I arm and 5 (1 while on PI/r and 4 after switching to DTG) in the DTG-D arm without selection of resistance mutations. There was no significant difference in terms of grade 3 or 4 AEs or treatment-modifying AEs. Total cholesterol and other lipid fractions (except high-density lipoprotein) significantly (P < .001) improved both after immediate and deferred switching to DTG overall and regardless of baseline PI/r strata.
Conclusions
Both immediate and deferred switching from a PI/r to a DTG regimen in virologically suppressed HIV-infected patients ≥50 years old or with a Framingham score ≥10% was highly efficacious and well tolerated, and improved the lipid profile
Multiscale Modeling of Single-Phase Multicomponent Transport in the Cathode Gas Diffusion Layer of a Polymer Electrolyte Fuel Cell
This document is the Accepted Manuscript version of a Published Work that appeared in final form in
Energy and Fuels, copyright © American Chemical Society after peer review and technical editing by the publisher.
To access the final edited and published work see: http://dx.doi.org/10.1021/ef100190cThis research reports a feasibility study into multiscale polymer electrolyte fuel cell (PEFC) modeling through the simulation of macroscopic flow in the multilayered cell via one-dimensional (1D) electrochemical modeling, and the simulation of microscopic flow in the cathode gas diffusion layer (GDL) via three-dimensional (3D) single-phase multicomponent lattice Boltzmann (SPMC-LB) modeling. The heterogeneous porous geometry of the carbon-paper GDL is digitally reconstructed for the SPMC-LB model using X-ray computer microtomography. Boundary conditions at the channel and catalyst layer interfaces for the SPMC-LB simulations such as specie partial pressures and through-plane flowrates are determined using the validated 1D electrochemical model, which is based on the general transport equation (GTE) and volume-averaged structural properties of the GDL. The calculated pressure profiles from the two models are cross-validated to verify the SPMC-LB technique. The simulations reveal a maximum difference of 2.4% between the thickness-averaged pressures calculated by the two techniques, which is attributable to the actual heterogeneity of the porous GDL structure
Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
BACKGROUND: We aimed to describe the most frequently prescribed initial antiretroviral therapy (ART) regimens in recent years in HIV-positive persons in the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) and to investigate factors associated with the choice of each regimen. METHODS: We analyzed initial ART regimens prescribed in adults participating in CoRIS from 2014 to 2017. Only regimens prescribed in >5% of patients were considered. We used multivariable multinomial regression to estimate Relative Risk Ratios (RRRs) for the association between sociodemographic and clinical characteristics and the choice of the initial regimen. RESULTS: Among 2874 participants, abacavir(ABC)/lamivudine(3TC)/dolutegavir(DTG) was the most frequently prescribed regimen (32.1%), followed by tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC)/elvitegravir(EVG)/cobicistat(COBI) (14.9%), TDF/FTC/rilpivirine (RPV) (14.0%), tenofovir alafenamide (TAF)/FTC/EVG/COBI (13.7%), TDF/FTC+DTG (10.0%), TDF/FTC+darunavir/ritonavir or darunavir/cobicistat (bDRV) (9.8%) and TDF/FTC+raltegravir (RAL) (5.6%). Compared with ABC/3TC/DTG, starting TDF/FTC/RPV was less likely in patients with CD4100.000 copies/mL. TDF/FTC+DTG was more frequent in those with CD4100.000 copies/mL. TDF/FTC+RAL and TDF/FTC+bDRV were also more frequent among patients with CD4<200 cells//muL and with transmission categories other than men who have sex with men. Compared with ABC/3TC/DTG, the prescription of other initial ART regimens decreased from 2014-2015 to 2016-2017 with the exception of TDF/FTC+DTG. Differences in the choice of the initial ART regimen were observed by hospitals' location. CONCLUSIONS: The choice of initial ART regimens is consistent with Spanish guidelines' recommendations, but is also clearly influenced by physician's perception based on patient's clinical and sociodemographic variables and by the prescribing hospital location
Analyses of Experiments on the Effect of Boric Acid on Caesium Transport with the RAFT and VICTORIA Computer Codes
Abstract not availableNA-NOT AVAILABL
Aerosol Resuspension in the Reactor Cooling System of LWRs under Severe Accident Conditions
Abstract not availableNA-NOT AVAILABL
Recommended from our members
Results of Aerosol Code Comparisons With Releases From ACE MCCI Tests
Results of aerosol release calculations by six groups from six countries are compared with the releases from ACE MCCI Test L6. The codes used for these calculations included: SOLGASMIX-PV, SOLGASMIX Reactor 1986, CORCON.UW, VANESA 1.01, and CORCON mod2.04/VANESA 1.01. Calculations were performed with the standard VANESA 1.01 code and with modifications to the VANESA code such as the inclusion of various zirconium-silica chemical reactions. Comparisons of results from these calculations were made with Test L6 release fractions for U, Zr, Si, the fission-product elements Te, Ba, Sr, Ce, La, Mo and control materials Ag, In, and Ru. Reasonable agreement was obtained between calculations and Test L6 results for the volatile elements Ag, In and Te. Calculated releases of the low volatility fission products ranged from within an order of magnitude to five orders of magnitude of Test L6 values. Releases were over and underestimated by calculations. Poorest agreements were obtained for Mo and Si
Recommended from our members
Results of aerosol code comparisons with releases from ACE MCCI tests
Results of aerosol release calculations by six groups from six countries are compared with the releases from ACE MCCI Test L6. The codes used for these calculations included: SOLGASMIX-PV, SOLGASMIX Reactor 1986, CORCON.UW, VANESA 1.01, and CORCON mod2.04/VANESA 1.01. Calculations were performed with the standard VANESA 1.01 code and with modifications to the VANESA code such as the inclusion of various zirconium-silica chemical reactions. Comparisons of results from these calculations were made with Test L6 release fractions for U, Zr, Si, the fission-product elements Te, Ba, Sr, Ce, La, Mo and control materials Ag, In, and Ru. Reasonable agreement was obtained between calculations and Test L6 results for the volatile elements Ag, In and Te. Calculated releases of the low volatility fission products ranged from within an order of magnitude to five orders of magnitude of Test L6 values. Releases were over and underestimated by calculations. Poorest agreements were obtained for Mo and Si
Condensation of fission product vapours onto aerosol particles and surfaces
Μη διαθέσιμη περίληψηNot available summarizationΠαρουσιάστηκε στο: European TwoPhase flow group meetin